Cover Image
市場調查報告書

3D生物印刷市場:推動因素,障礙,趨勢

Global 3D Bioprinting Market - Segmented By Technology (Syringe/Extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting), Component, Applications And Geography - Growth, Trends, And Forecasts (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 393543
出版日期 內容資訊 英文 105 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
3D生物印刷市場:推動因素,障礙,趨勢 Global 3D Bioprinting Market - Segmented By Technology (Syringe/Extrusion Bioprinting, Inkjet Bioprinting, Magnetic Levitation Bioprinting), Component, Applications And Geography - Growth, Trends, And Forecasts (2018 - 2023)
出版日期: 2018年02月08日 內容資訊: 英文 105 Pages
簡介

本報告提供全球3D生物印刷市場相關調查分析,市場概要,各市場區隔的市場分析,競爭情形,主要企業,未來預測等系統性資訊。

第1章 簡介

第2章 摘要整理

第3章 目前市場趨勢

  • 市場概要
  • 技術概述
  • 推動市場要素
  • 阻礙市場要素

第4章 3D培養基材業者簡介

  • 3D Biotek
  • Reinnervate Ltd
  • Life Technologies
  • SCIVAX Corporation
  • Nanofiber Solutions
  • The Electrospinning Company Ltd
  • Matricel
  • Insphero
  • Boca Scientific, Inc.
  • GeSim

第5章 3D細胞印刷企業

  • Organavo
  • OxSyBio
  • Aspect Biosystems
  • EnvisionTec
  • Nano3D Biosciences, Inc.
  • Rainbow Coral Corp.
  • 3D Bio printing Solutions
  • TeVido

第6章 3D生物印刷市場前途

第7章 投資分析

  • 商務推動因素所扮演的角色
  • 投資公司策略和最近的投資

第8章 3D生物印刷的未來

第9章 表格的清單

第10章 圖的清單

第11章 簡稱

第12章 引用

第13章 免責聲明

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 1299

Description

The global 3D bioprinting market is expected register a CAGR of 22.35% during the forecast period (2018 - 2023). 3D printer manufacturing companies are working toward building a human tissue for surgical therapy and transplantation. Developments such as this are expected to propel the market for global 3D bioprinting, which is expected to witness a significant growth, owing to technological advancements, government intervention for improving healthcare, and increasing investments in R&D. Global players are increasingly exploring 3D bioprinting as it reduces the risks associated with anesthesia during long surgeries and helps improve healthcare services.

INCREASING PERCENTAGE OF GERIATRIC POPULATION

The percentage of aged population (>65 years) is increasing gradually. It is a strong indicator for the growth of the 3D bioprinter market, as elderly population is more prone toward organ related ailments. Japan has the highest percentage of geriatric population in the world. The market for 3D bioprinters, which is designed for dentistry applications, is expected to witness a good growth rate, more so due to the rising geriatric population. These 3D bioprinters can be used by dentists to create friendlier implants and prosthetics by utilizing the patient's unique teeth layout and bone scans. Trailing Japan, countries in the western hemisphere have a high percentage of aged population, which is rising continuously, driving the demand for 3D bioprinters.

DRUG DISCOVERY RESEARCH TO GAIN TRACTION OVER THE FORECAST PERIOD

Drug discovery is a highly expensive process, and in most cases, it fails in gaining regulatory clearance. One of the major expenses for a pharmaceutical company in the United States is the completion of FDA's approval process. Over USD 50 billion is being spent on R&D in the country, annually. Interestingly, only one in 5000 drugs makes it to the market, leading to huge financial burden on drug manufacturing companies. The reason for this failure is the lack of accurate pre-clinical testing methods. The drug, which passed the in-vitro and animal testing stages, stands a high chance of failing in clinical trials, forcing manufacturers to start from the beginning. Medical researchers in order to make the drug discovery process more reliable are seeking means to mimic the 3-dimensional human tissue environment. With the advent of 3D bioprinting, manufacturers will be able to reduce complications associated with human clinical trials of novel drugs, reducing the losses incurred during late stage failures and shortening the drug discovery time, thus, driving the market for this technology.

UNITED STATES TO HOLD MAJOR SHARE IN NORTH AMERICA

Despite advances in medicine and technology, increased awareness about organ donation and transplantation, the gap between supply and demand continues to widen in the country. The number of people on the national waiting list continue to grow, while rates of donation and transplant stagnate. Currently, there are about 122,480 people in the waiting list in need of a lifesaving transplant, whereas, only 20,704 transplants were performed in 2016. It is estimated that on an average 22 people die each day while waiting for a transplant. 3D bioprinting is observed as the most promising solution to meet high demand for suitable organs for transplantation, driving the growth of the market in the region. In addition, the cost of organ transplantation is very high. The estimated average cost for heart, liver, and kidney transplants, are about USD 997,000, USD 577,000, and USD 262,000, respectively. Researchers are focusing on 3D bioprinting, which is seen as a viable alternative, which will help in driving the market.

Major Key Players: 3D Systems, Aspect Biosystems, Gesim, Bio3d, Organovo Holdings Inc.

KEY DEVELOPMENTS IN THE STUDY

January 2018: BASF and CTI biotech have developed functional skin gland models with 3D printing. The research involved the use of 3D human sebaceous gland modeling by CTI Biotech. This regenerative medicine R&D company specializes in studies of skin cosmetics, stem-cells and cancer, having recently installed a CELLINK BIO X 3D printer to develop treatments for the latter.

January 2018: Swedish biotech company, Cellink, has begun fabricating tumors in an effort to combat cancer. The company, which became known in 2016, has risen to fame as a result of its biological ink, designed to be used by a variety of 3D printers to create different types of cell tissues.

Reasons to Purchase this Report

To know - how the market scenario of 3D bioprinting is changing

Analyzing various perspectives of the market with the help of Porter's five forces analysis

To know which security technology, services, and vertical are expected to dominate the market

The regions that are expected to witness fastest growth during the forecast period

Identify the latest developments, market shares, and strategies employed by the major market players

Three months of analyst support, along with the Market Estimate sheet (in excel)

Customization of the Report

This report can be customized to meet your requirements.

Table of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Executive Summary

2. Research Methodology

  • 2.1 Study Deliverables
  • 2.2 Study Assumptions
  • 2.3 Research Methodology
  • 2.4 Research Phases

3. Market Insights

  • 3.1 Market Overview
  • 3.2 Porter's Five Forces Analysis
    • 3.2.1 Threat of New Entrants
    • 3.2.2 Bargaining Power of customers
    • 3.2.3 Bargaining Power of Suppliers
    • 3.2.4 Threat of Substitute products
    • 3.2.5 Intensity of Competitive Rivalry
  • 3.3 Industry Value Chain Analysis

4. Market Dynamics

  • 4.1 Introduction
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population
    • 4.2.2 Increasing Investment in R&D
    • 4.2.3 Increasing Transplant Requirement
    • 4.2.4 Rising Costs of Drug Development
  • 4.3 Market Restraints
    • 4.3.1 High Initial Costs
    • 4.3.2 Lack of Skilled Professional

5. Global 3D Bioprinting Market - Segmentation, by Technology

  • 5.1 SyriEge/extrusion Bioprinting
  • 5.2 Inkjet Bioprinting
  • 5.3 Magnetic Levitation Bioprinting
  • 5.4 Laser-assisted Bioprinting
  • 5.5 Others

6. Global 3D Bioprinting Market - Segmentation, by Component

  • 6.1 3D Bioprinters
  • 6.2 Biomaterials
    • 6.2.1 Bio-ink
    • 6.2.2 Bio-paper Gel
  • 6.3 Scaffolds
  • 6.4 Others

7. Global 3D Bioprinting Market - Segmentation, by Application

  • 7.1 Toxicity Testing
  • 7.2 Drug Discovery Research
  • 7.3 Transplantation
  • 7.4 Surgical Therapy
  • 7.5 Reconstructive Surgery
  • 7.6 Others

8. Global 3D Bioprinting Market - Segmentation, by Geography

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
  • 8.2 Europe
    • 8.2.1 Germany
    • 8.2.2 United Kingdom
    • 8.2.3 France
    • 8.2.4 Others
  • 8.3 Asia-Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 Others
  • 8.4 Latin America
    • 8.4.1 Brazil
    • 8.4.2 Argentina
    • 8.4.3 Mexico
    • 8.4.4 Others
  • 8.5 Middle East & Africa
    • 8.5.1 United Arab Emirates
    • 8.5.2 Saudi Arabia
    • 8.5.3 South Africa
    • 8.5.4 Others

9. Competitive Intelligence - Company Profiles

  • 9.1 3D Systems Corp.
  • 9.2 Aspect Biosystems Ltd
  • 9.3 GeSIM GmbH
  • 9.4 Bio3D Technologies
  • 9.5 BioBots, Inc.
  • 9.6 Cyfuse Biomedical KK
  • 9.7 Envision TEC GmbH
  • 9.8 Organovo Holdings Inc
  • 9.9 RegenHU SA
  • 9.10 Stratasys Ltd
  • 9.11 TeVido Biodevices, Inc.
  • 9.12 3D Bioprinting Solutions

10. Investment Analysis

11. Future of the 3D Bioprinting Market

Back to Top